Lockheed Martin has now fallen 7% over the past month to $522.34, extending the slide that was already the central tension in last week's note — and the gap between where the stock trades and where analysts think it should be has only grown wider.
The price action this week reinforced the pressure. LMT dropped another 2.1% on the week and 2.4% on Tuesday alone, closing at $522.34. Close peers moved in the same direction but more sharply: NOC fell 4.0% on the week and GD lost 4.2%, while RTX slipped 2.3%. Lockheed actually held up relatively well within the defense cohort, but the sector-wide selling pressure is real. With Q3 earnings scheduled for October 20, the stock is heading into the print having given back nearly all the gains from the post-Q2 spike in late July, when it jumped 13% in a single session.
The Street remains constructive — and the gap to consensus is now striking. The mean analyst price target stands at $640, implying roughly 23% upside from current levels, yet the consensus rating is still a Hold with 11 holds on the count. The most recent upgrade came from UBS on September 8, lifting to Buy with a $674 target when the stock was trading near $533. Since then the stock has continued lower, not higher, making that call look premature so far. Citigroup has a $691 target and Morgan Stanley $690, both from post-Q2 revisions, while RBC sits at $600 on a Sector Perform. The bull case — strong 4Q25 cash flow, a pre-funded 2026 pension, and FCF guidance raised 10%-plus — has not changed. Neither has the bear case: the NGAD program loss, F-35 execution risk, and potential federal budget constraints remain the headline concerns. Factor scores add nuance: the analyst recommendation divergence ranks in the 94th percentile, meaning the spread between bull and bear views on this stock is unusually wide relative to the broader market. The dividend score also ranks at 94, reflecting the company's consistent capital return profile even as growth momentum scores — EPS momentum ranks at 32 on a 30-day basis — have softened.
Options positioning suggests the selloff has not yet triggered a rush for downside protection. The put/call ratio came in at 0.78, running slightly below its 20-day average of 0.82 and 1.3 standard deviations below that mean. For a stock down 7% on the month heading into earnings, that is a notably relaxed reading. The 52-week range for the PCR runs from 0.47 to 1.04, so current levels are in the middle-lower third — call buying is modestly elevated relative to recent history, which could reflect either recovery positioning or covered-call writing by holders managing downside. Short interest is not a meaningful part of this story: at 1.2% of free float, it is low and has barely moved, up only 0.5% on the week. Borrow availability is extraordinarily loose — over 6,500% of short interest is available to lend — and cost to borrow at 0.42% is near-negligible. There is no short-side pressure in the lending market.
The one area worth monitoring from an ownership angle is the earnings reaction history. The July Q2 print produced a 13.3% single-day move and a 11.6% five-day gain — an unusually large reaction for a stock of this size and stability profile. The prior quarter's result was far more muted at under 1% on the day, before rallying 14% over the following week. That inconsistency makes the October 20 print harder to read: the stock has a demonstrated ability to swing sharply in either direction depending on what guidance and contract updates management delivers. Insider activity over the 90-day window has been modest selling — director John Donovan and Space division president Robert Lightfoot both sold shares in August, totalling a net 5,984 shares, though at prices well above the current level — not a high-conviction signal either way.
What to watch next is whether the stock can stabilise above the $520 level heading into October 20, and whether the options market starts pricing in a larger implied move as the earnings date draws closer.
See the live data behind this article on ORTEX.
Open LMT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
